Passumpsic Savings Bank Has $4.05 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Passumpsic Savings Bank decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the 4th quarter, HoldingsChannel reports. The firm owned 7,763 shares of the medical equipment provider’s stock after selling 226 shares during the quarter. Intuitive Surgical accounts for 2.5% of Passumpsic Savings Bank’s portfolio, making the stock its 10th largest holding. Passumpsic Savings Bank’s holdings in Intuitive Surgical were worth $4,052,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Bradley Foster & Sargent Inc. CT raised its stake in Intuitive Surgical by 1.7% during the fourth quarter. Bradley Foster & Sargent Inc. CT now owns 41,908 shares of the medical equipment provider’s stock worth $21,874,000 after acquiring an additional 719 shares in the last quarter. Compass Capital Corp MA ADV acquired a new position in Intuitive Surgical during the fourth quarter worth about $506,000. Centricity Wealth Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth about $47,000. Tandem Investment Advisors Inc. raised its stake in Intuitive Surgical by 1.9% during the fourth quarter. Tandem Investment Advisors Inc. now owns 9,954 shares of the medical equipment provider’s stock worth $5,196,000 after acquiring an additional 182 shares in the last quarter. Finally, Prakash Investment Advisors LLC acquired a new position in Intuitive Surgical during the fourth quarter worth about $1,201,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $591.79 on Friday. The business’s 50 day simple moving average is $565.45 and its 200 day simple moving average is $524.52. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market capitalization of $210.78 billion, a PE ratio of 92.32, a PEG ratio of 5.87 and a beta of 1.39.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Jefferies Financial Group boosted their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Wells Fargo & Company upped their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.